NYSE:USNA - USANA Health Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $104.39 +0.38 (+0.37 %) (As of 10/21/2018 07:20 AM ET)Previous Close$104.39Today's Range$103.94 - $107.4252-Week Range$60.20 - $137.95Volume136,382 shsAverage Volume113,565 shsMarket Capitalization$2.53 billionP/E Ratio22.31Dividend YieldN/ABeta0.61 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé?beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Receive USNA News and Ratings via Email Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Medicinals & botanicals Sub-IndustryPersonal Products SectorMedical SymbolNYSE:USNA CUSIP90328M10 Webwww.usana.com Phone801-954-7100 Debt Debt-to-Equity RatioN/A Current Ratio2.96 Quick Ratio2.42 Price-To-Earnings Trailing P/E Ratio22.31 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.05 billion Price / Sales2.42 Cash Flow$4.8508 per share Price / Cash21.52 Book Value$15.14 per share Price / Book6.89 Profitability EPS (Most Recent Fiscal Year)$4.06 Net Income$62.53 million Net Margins7.16% Return on Equity29.50% Return on Assets21.55% Miscellaneous Employees1,810 Outstanding Shares24,250,000Market Cap$2.53 billion USANA Health Sciences (NYSE:USNA) Frequently Asked Questions What is USANA Health Sciences' stock symbol? USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA." How will USANA Health Sciences' stock buyback program work? USANA Health Sciences declared that its Board of Directors has initiated a share buyback plan on Wednesday, July 26th 2017, which authorizes the company to repurchase $64,600,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 46% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its stock is undervalued. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) posted its quarterly earnings results on Tuesday, July, 24th. The company reported $1.36 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.25. The business had revenue of $301.50 million for the quarter, compared to analyst estimates of $278.41 million. USANA Health Sciences had a return on equity of 29.50% and a net margin of 7.16%. The company's revenue was up 17.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.98 earnings per share. View USANA Health Sciences' Earnings History. When is USANA Health Sciences' next earnings date? USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, October 23rd 2018. View Earnings Estimates for USANA Health Sciences. What guidance has USANA Health Sciences issued on next quarter's earnings? USANA Health Sciences issued an update on its FY18 earnings guidance on Tuesday, July, 24th. The company provided earnings per share (EPS) guidance of $4.75-5.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.56. The company issued revenue guidance of $1.15 billion, compared to the consensus revenue estimate of prior $4.25-4.55. What price target have analysts set for USNA? 2 equities research analysts have issued 1 year price objectives for USANA Health Sciences' shares. Their predictions range from $135.00 to $135.00. On average, they expect USANA Health Sciences' share price to reach $135.00 in the next twelve months. This suggests a possible upside of 29.3% from the stock's current price. View Analyst Price Targets for USANA Health Sciences. What is the consensus analysts' recommendation for USANA Health Sciences? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for USANA Health Sciences. Who are some of USANA Health Sciences' key competitors? Some companies that are related to USANA Health Sciences include STADA Arzneimittel (STDAF), Cronos Group (CRON), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), Natural Alternatives International (NAII), Pharmacyte Biotech (PMCB), China Jo-Jo Drugstores (CJJD), Mannatech (MTEX), GLG Life Tech (GLGLF), Cyanotech (CYAN), Conversion Labs (CVLB), ImmuDyne (IMMD), FitLife Brands (FTLF) and Tauriga Sciences (TAUG). Who are USANA Health Sciences' key executives? USANA Health Sciences' management team includes the folowing people: Dr. Myron W. Wentz, Founder & Chairman (Age 77)Mr. Kevin G. Guest, CEO & Director (Age 55)Mr. Jim Brown, Pres & COO (Age 49)Mr. G. Douglas Hekking, Chief Financial Officer (Age 48)Mr. Daniel A. Macuga Jr., Chief Communications & Marketing Officer (Age 48) Who are USANA Health Sciences' major shareholders? USANA Health Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Aperio Group LLC (0.11%), Bowling Portfolio Management LLC (0.06%), Seven Eight Capital LP (0.06%), Strs Ohio (0.03%), Strategic Advisors LLC (0.01%) and NEXT Financial Group Inc (0.00%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences. Which institutional investors are selling USANA Health Sciences stock? USNA stock was sold by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, Aperio Group LLC and Strs Ohio. Company insiders that have sold USANA Health Sciences company stock in the last year include Daniel A Macuga, David Mulham Mulham, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott and Walter Noot. View Insider Buying and Selling for USANA Health Sciences. Which institutional investors are buying USANA Health Sciences stock? USNA stock was purchased by a variety of institutional investors in the last quarter, including Seven Eight Capital LP, Strategic Advisors LLC and NEXT Financial Group Inc. View Insider Buying and Selling for USANA Health Sciences. How do I buy shares of USANA Health Sciences? Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is USANA Health Sciences' stock price today? One share of USNA stock can currently be purchased for approximately $104.39. How big of a company is USANA Health Sciences? USANA Health Sciences has a market capitalization of $2.53 billion and generates $1.05 billion in revenue each year. The company earns $62.53 million in net income (profit) each year or $4.06 on an earnings per share basis. USANA Health Sciences employs 1,810 workers across the globe. What is USANA Health Sciences' official website? The official website for USANA Health Sciences is http://www.usana.com. How can I contact USANA Health Sciences? USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected] MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 225 (Vote Outperform)Underperform Votes: 333 (Vote Underperform)Total Votes: 558MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/21/2018 by MarketBeat.com StaffFeatured Article: Does the discount rate affect the economy?